Ginsenoside Metabolite Compound K Promotes Recovery of Dextran Sulfate Sodium-Induced Colitis and Inhibits Inflammatory Responses by Suppressing NF-κB Activation

Autor: Gang Song, Shaoping Hu, Bing Zhang, Jiahui Yuan, Weiwei Wang, Tianhui Hu, Wei Zhong, Juan Li
Rok vydání: 2014
Předmět:
Mouse
Berberine
Metabolite
medicine.medical_treatment
Cancer Treatment
lcsh:Medicine
Pharmacology
Biochemistry
Inflammatory bowel disease
Mice
chemistry.chemical_compound
Drug Discovery
Gastrointestinal Cancers
Medicine
lcsh:Science
Multidisciplinary
biology
Anti-Inflammatory Agents
Non-Steroidal

Dextran Sulfate
NF-kappa B
Animal Models
Colitis
Cytokine
Oncology
Myeloperoxidase
Cytokines
Inflammation Mediators
medicine.symptom
Immunohistochemical Analysis
Research Article
Signal Transduction
Drugs and Devices
Drug Research and Development
Colon
Immunology
Inflammation
Gastroenterology and Hepatology
Cell Line
Rectal Cancer
Model Organisms
Complementary and Alternative Medicine
Gastrointestinal Tumors
Ulcerative Colitis
Animals
Biology
Peroxidase
business.industry
Macrophages
lcsh:R
Inflammatory Bowel Disease
Immunity
Cancers and Neoplasms
medicine.disease
NFKB1
Disease Models
Animal

IκBα
chemistry
Immune System
Immunologic Techniques
biology.protein
lcsh:Q
Clinical Immunology
business
Zdroj: PLoS ONE
PLoS ONE, Vol 9, Iss 2, p e87810 (2014)
ISSN: 1932-6203
Popis: Phytogenic compounds with anti-oxidant and anti-inflammatory properties, such as ginsenoside metabolite compound K (CK) or berberine (BBR), are currently discussed as promising complementary agents in the prevention and treatment of cancer and inflammation. The latest study showed that ginsenoside Rb1 and its metabolites could inhibit TNBS-induced colitis injury. However, the functional mechanisms of anti-inflammation effects of ginsenoside, particularly its metabolite CK are still not clear. Here, using dextran sulfate sodium (DSS)-induced colitis in mice, clinical parameters, intestinal integrity, pro-inflammatory cytokines production, and signaling pathways in colonic tissues were determined. In mild and sever colitis mice, CK and BBR (as a positive agent) alleviated colitis histopathology injury, ameliorated myeloperoxidase (MPO) activity, reduced pro-inflammatory cytokines production, such as, IL-6, IL-1β, TNF-α, and increased anti-inflammatory cytokine IL-10 production in both mice colon tissues and blood. Nevertheless, the results revealed that CK and BBR inhibited NF-κB p65 nuclear translocation, downregulated p-IκBα and upregulated IκBα, indicating that CK, as well as BBR, suppressed the activation of the NF-κB pathway in the progression of colitis with immunofluorescence, immunohistochemical and western blotting analysis. Furthermore, CK inhibited pro-inflammatory cytokines production in LPS-activated macrophages via down-regulation of NF-κB signaling pathway. Taken together, our results not only reveal that CK promotes the recovery of the progression of colitis and inhibits the inflammatory responses by suppressing NF-κB activation, but also suggest that CK downregulates intestinal inflammation through regulating the activation of macrophages and pro-inflammatory cytokines production.
Databáze: OpenAIRE